Current insight into the roles of microRNA 25-5p and microphthalmia-associated transcription factor in the pathogenesis of non-segmental vitiligo

Assessment of Interleukin-12 Gene Polymorphism in Vitiligo Patients

Evaluation of Interleukin-23 Receptor Gene Polymorphism in Vitiligo Patients

Role of Isocitrate Dehydrogenase 2, Microphthalmia-Associated Transcription Factor and Alpha Melanocyte Stimulating Hormone in Patients with Non-Segmental Generalized Vitiligo

A Study of Plasma miR-23a Expression in Vitiligo Patients

Serum Interleukin 19 in Patients with Vitiligo

Serum CCL20 Level in Patients with Vitiligo

Measurement of Serum Prolactin Level in Vitiligo Patients and its Correlation with Prolactin Gene Polymorphism

Serum level of YKL-40, C-reactive protein and ESR in Patients with Vitiligo

Serum MicroRNA-155 Expression Level as a Novel Biomarker in Alopecia Areata Patients